Pulmonx Corporation
LUNG$54M
Micro CapNASDAQSurgical & Medical Instruments & Apparatus🇺🇸North AmericaREDWOOD CITY291 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
LUNG News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
How LUNG's past catalysts played out
Drug Pipeline
No drugs found in this phase.
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is Pulmonx Corporation's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Pulmonx Corporation (LUNG) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track LUNG biotech catalysts?→
Add LUNG to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Pulmonx Corporation's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply